Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) commences share repurchases on September 22, 2023, under the program mandated by the shareholders in the Extraordinary General Meeting of Shareholders held on September 13, 2023. As per the mandate, the company is authorized to repurchase up to repurchase up to CNY 400 million worth of its shares. The shares will be repurchased at a price not more than CNY 98 per share.

The repurchased shares will be used to decrease the company?s registered capital. The program will be funded from company's own funds. The program will be valid till 12 months.